MDXG CIK: 1376339

MiMedx Group, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
149
FY22:
134
FY23:
164
FY24:
192
FY25:
277
(positive)
Change from FY21 to FY25
millions USD
FY21:
39.4
FY22:
37.2
FY23:
74.8
FY24:
72.0
FY25:
65.2
Total assets
Change from FY21 to FY25
millions USD
FY21:
188
FY22:
171
FY23:
239
FY24:
264
FY25:
343

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
42.4
FY22:
43.6
FY23:
46.0
FY24:
45.6
FY25:
64.3
(negative)
Change from FY21 to FY25
millions USD
FY21:
53.0
FY22:
53.4
FY23:
50.3
FY24:
25.2
FY25:
21.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.08
FY22:
−18.0
FY23:
143
FY24:
193
FY25:
257
Total liabilities & equity
Change from FY23 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
239
FY24:
264
FY25:
343

All amounts in millions USD Data source:SEC EDGAR